Gilead Sciences' earnings conference calls for Q1 2024 and Q4 2023 provide insights into its financial performance. We also explore Affirm Holdings, 3M, and Gilead Sciences in a stock lunch. My thoughts on Gilead stock and the biotech sector offer a broader perspective on the industry's trends and prospects.